Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Tracing Technique Untangles Brain Circuit Networks

By BiotechDaily International staff writers
Posted on 09 Jul 2013
Print article
Image: Neurons in the basal ganglia (Photo courtesy of Anatol Kreitzer, PhD, Gladstone Institutes).
Image: Neurons in the basal ganglia (Photo courtesy of Anatol Kreitzer, PhD, Gladstone Institutes).
High-resolution mapping has uncovered the architecture of neural circuits leading to the basal ganglia, which could promote research into disorders such as Parkinson’s disease (PD) and Huntington’s disease.

Researchers at the Gladstone Institutes (San Francisco, CA, USA) and the Salk Institute (San Diego, CA, USA) combined mouse models with a sophisticated tracing technique, known as the monosynaptic rabies virus (MRV) system, to assemble brain-wide maps of the striatum of neurons that connect with the basal ganglia, integrating information from multiple brain regions to shape motor learning. The two major projection cell types in the striatum target different downstream basal ganglia targets and have opposing effects on motivated behavior, yet differential innervation of these neuronal subtypes is not well understood.

To examine whether input specificity provides a basis for information segregation, the researchers used a MRV system to generate brain-wide maps of neurons that form synapses with direct- or indirect-pathway striatal projection neurons. They found that sensory cortical and limbic structures mostly innervated the direct pathway, whereas motor cortex structures preferentially targeted the indirect pathway. The researchers also found that thalamostriatal input, dopaminergic input, and input from specific cortical layers were similar in both pathways. The study was published on June 26, 2013, in Neuron.

“Taming and harnessing the rabies virus is ingenious in the exquisite precision that it offers compared with previous methods, which were messier with a much lower resolution,” said study coauthor Anatol Kreitzer, PhD, of the Gladstone Institutes. “We took the approach one step further by activating the tracer genetically, which ensures that it is only turned on in specific neurons in the basal ganglia. This is a huge leap forward technologically, as we can be sure that we’re following only the networks that connect to particular kinds of cells in the basal ganglia.”

“These initial results should be treated as a resource not only for decoding how this network guides the vast array of very distinct brain functions, but also how dysfunctions in different parts of this network can lead to different neurological conditions,” added coauthor Edward Callaway, PhD, of the Salk Institute. “If we can use the rabies virus system to pinpoint distinct network disruptions in distinct types of disease, we could significantly improve our understanding of these diseases’ underlying molecular mechanisms and get even closer to developing solutions for them.”

The MRV system, originally developed in 2007 and refined by Dr. Callaway and other researchers for targeting specific cell types in 2010, uses a modified version of the rabies virus to “infect” a brain region, which in turn targets and infects neurons that are connected to it. When the system was applied in genetic mouse models, the team could see specifically how sensory, motor, and reward structures in the brain connected to medium spiny neurons (MSNs) in the basal ganglia.

Related Links:

Gladstone Institutes
Salk Institute



Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.